Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects With Treatment Resistant Herpes Simplex Virus Type 1 or 2

Condition:   HSV Intervention:   Drug: Pritelivir Sponsors:   AiCuris Anti-infective Cures AG;   Impatients N.V. trading as myTomorrows Available

Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials